Acquired mutations in TET2 are common in myelodysplastic syndromes
- PMID: 19483684
- DOI: 10.1038/ng.391
Acquired mutations in TET2 are common in myelodysplastic syndromes
Abstract
Myelodysplastic syndromes (MDS) represent a heterogeneous group of neoplastic hematopoietic disorders. Several recurrent chromosomal aberrations have been associated with MDS, but the genes affected have remained largely unknown. To identify relevant genetic lesions involved in the pathogenesis of MDS, we conducted SNP array-based genomic profiling and genomic sequencing in 102 individuals with MDS and identified acquired deletions and missense and nonsense mutations in the TET2 gene in 26% of these individuals. Using allele-specific assays, we detected TET2 mutations in most of the bone marrow cells (median 96%). In addition, the mutations were encountered in various lineages of differentiation including CD34(+) progenitor cells, suggesting that TET2 mutations occur early during disease evolution. In healthy tissues, TET2 expression was shown to be elevated in hematopoietic cells with highest expression in granulocytes, in line with a function in myelopoiesis. We conclude that TET2 is the most frequently mutated gene in MDS known so far.
Comment in
-
TET2 mutations in myelodysplasia and myeloid malignancies.Nat Genet. 2009 Jul;41(7):766-7. doi: 10.1038/ng0709-766. Nat Genet. 2009. PMID: 19557078
Similar articles
-
Mutation in TET2 in myeloid cancers.N Engl J Med. 2009 May 28;360(22):2289-301. doi: 10.1056/NEJMoa0810069. N Engl J Med. 2009. PMID: 19474426
-
Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.Int J Clin Exp Pathol. 2015 Sep 1;8(9):10840-6. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26617797 Free PMC article.
-
Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value.Blood. 2010 Nov 11;116(19):3923-32. doi: 10.1182/blood-2010-03-274704. Epub 2010 Aug 6. Blood. 2010. PMID: 20693430
-
Mutations of myelodysplastic syndromes (MDS): An update.Mutat Res Rev Mutat Res. 2016 Jul-Sep;769:47-62. doi: 10.1016/j.mrrev.2016.04.009. Epub 2016 Jun 23. Mutat Res Rev Mutat Res. 2016. PMID: 27543316 Review.
-
[An update on epigenetic regulator gene mutations and pathogenesis of myelodysplastic syndromes].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Oct;19(5):1303-9. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011. PMID: 22040993 Review. Chinese.
Cited by
-
MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling.Cell. 2013 Jul 18;154(2):311-324. doi: 10.1016/j.cell.2013.06.026. Epub 2013 Jul 3. Cell. 2013. PMID: 23830207 Free PMC article.
-
G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells.Small GTPases. 2015;6(2):100-3. doi: 10.4161/21541248.2014.988088. Epub 2015 Jun 23. Small GTPases. 2015. PMID: 26103434 Free PMC article. Review.
-
CpG methylation recruits sequence specific transcription factors essential for tissue specific gene expression.Biochim Biophys Acta. 2012 Jul;1819(7):763-70. doi: 10.1016/j.bbagrm.2012.02.014. Epub 2012 Feb 23. Biochim Biophys Acta. 2012. PMID: 22387149 Free PMC article. Review.
-
TET family proteins: oxidation activity, interacting molecules, and functions in diseases.Chem Rev. 2015 Mar 25;115(6):2225-39. doi: 10.1021/cr500470n. Epub 2015 Feb 12. Chem Rev. 2015. PMID: 25675246 Free PMC article. Review. No abstract available.
-
Gene mutations of acute myeloid leukemia in the genome era.Int J Hematol. 2013 Feb;97(2):165-74. doi: 10.1007/s12185-013-1257-4. Epub 2013 Jan 29. Int J Hematol. 2013. PMID: 23359299 Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous